Recent studies indicate that ADAM10 is involved in the cleavage of a number of proteins such as the NOTCH receptor, its ligand DLL1 and other proteins influencing the metastatic potential of tumor cells through EMT (N-cadherin, E-cadherin, B-catenin). Here, DLL1 is linked to neoplasm.